Loading...
Market
Will Australia's mRNA facility produce 50 million doses by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Production reports or official statements from the facility or Australian health authorities
Story
Australia Opens First mRNA Vaccine Facility, Government Maintains Vaccine Use Amid Safety Concerns
Dec 4, 2024, 07:43 AM
The Australian government has announced that it will not suspend the use of mRNA COVID-19 vaccines, despite concerns raised by some scientists regarding potential health risks, including an increased risk of cancer. This decision coincides with the opening of Australia's first mRNA vaccine manufacturing facility, which has the capacity to produce up to 100 million vaccine doses annually. The facility is intended to bolster the country's ability to protect its population from illnesses and diseases. Vaccine skepticism persists among segments of the population, as debates about the safety and efficacy of mRNA technology continue.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-500,000 doses • 25%
500,001-1,000,000 doses • 25%
1,000,001-1,500,000 doses • 25%
1,500,001-2,000,000 doses • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
16+ countries • 25%
Less than 10 million • 25%
10-20 million • 25%
21-30 million • 25%
More than 30 million • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Less than 100,000 doses • 25%
100,000 to 199,999 doses • 25%
200,000 to 299,999 doses • 25%
300,000 or more doses • 25%
No response • 25%
Denial of contamination claims • 25%
Acknowledgement of contamination and corrective measures • 25%
Legal action against claimants • 25%